Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

References for PMC Articles for PubMed (Select 18847302)

1.

The X-files in immunity: sex-based differences predispose immune responses.

Fish EN.

Nat Rev Immunol. 2008 Sep;8(9):737-44. doi: 10.1038/nri2394. Review.

PMID:
18728636
2.

Vaccine immunogenetics: bedside to bench to population.

Poland GA, Ovsyannikova IG, Jacobson RM.

Vaccine. 2008 Nov 18;26(49):6183-8. doi: 10.1016/j.vaccine.2008.06.057. Epub 2008 Jul 1. Review.

3.

Vaccines: correlates of vaccine-induced immunity.

Plotkin SA.

Clin Infect Dis. 2008 Aug 1;47(3):401-9. doi: 10.1086/589862. Review.

4.

Learning to appreciate our differences.

Relman DA.

J Infect Dis. 2008 Jul 1;198(1):4-5. doi: 10.1086/588672. No abstract available.

5.

Genetic basis for adverse events after smallpox vaccination.

Reif DM, McKinney BA, Motsinger AA, Chanock SJ, Edwards KM, Rock MT, Moore JH, Crowe JE.

J Infect Dis. 2008 Jul 1;198(1):16-22. doi: 10.1086/588670. Erratum in: J Infect Dis. 2008 Sep 1;198(5):796.

6.

Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.

Ovsyannikova IG, Jacobson RM, Dhiman N, Vierkant RA, Pankratz VS, Poland GA.

Pediatrics. 2008 May;121(5):e1091-9. doi: 10.1542/peds.2007-1575.

7.

Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results.

Dhiman N, Ovsyannikova IG, Vierkant RA, Ryan JE, Pankratz VS, Jacobson RM, Poland GA.

Vaccine. 2008 Mar 25;26(14):1731-6. doi: 10.1016/j.vaccine.2008.01.017. Epub 2008 Feb 4.

8.

Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.

Deshpande A, Wheeler CM, Hunt WC, Peyton CL, White PS, Valdez YE, Nolan JP.

J Infect Dis. 2008 Feb 1;197(3):371-81. doi: 10.1086/524300.

9.

Pharmacology, vaccinomics, and the second golden age of vaccinology.

Poland GA.

Clin Pharmacol Ther. 2007 Dec;82(6):623-6. No abstract available.

PMID:
17998905
10.

Mass spectrometry and peptide-based vaccine development.

Ovsyannikova IG, Johnson KL, Bergen HR 3rd, Poland GA.

Clin Pharmacol Ther. 2007 Dec;82(6):644-52. Epub 2007 Oct 31. Review.

PMID:
17971823
11.

Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.

Poland GA, Ovsyannikova IG, Jacobson RM, Smith DI.

Clin Pharmacol Ther. 2007 Dec;82(6):653-64. Epub 2007 Oct 31. Review.

PMID:
17971814
12.

Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents.

Shrestha S, Wang C, Aissani B, Wilson CM, Tang J, Kaslow RA.

Cancer Epidemiol Biomarkers Prev. 2007 Aug;16(8):1626-32.

13.

Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP).

Marin M, G├╝ris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40.

14.

The immunogenetics of smallpox vaccination.

Stanley SL Jr, Frey SE, Taillon-Miller P, Guo J, Miller RD, Koboldt DC, Elashoff M, Christensen R, Saccone NL, Belshe RB.

J Infect Dis. 2007 Jul 15;196(2):212-9. Epub 2007 Jun 4.

15.

Genetic predisposition for adverse events after vaccination.

Crowe JE Jr.

J Infect Dis. 2007 Jul 15;196(2):176-7. Epub 2007 Jun 4. No abstract available.

16.

The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.

Mata-Haro V, Cekic C, Martin M, Chilton PM, Casella CR, Mitchell TC.

Science. 2007 Jun 15;316(5831):1628-32.

17.

Immunology. The shape of things to come.

Fitzgerald KA, Golenbock DT.

Science. 2007 Jun 15;316(5831):1574-6. No abstract available.

PMID:
17569850
18.

Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors.

Dhiman N, Poland GA, Cunningham JM, Jacobson RM, Ovsyannikova IG, Vierkant RA, Wu Y, Pankratz VS.

J Allergy Clin Immunol. 2007 Sep;120(3):666-72. Epub 2007 Jun 8.

PMID:
17560639
19.

Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.

Perera LP, Waldmann TA, Mosca JD, Baldwin N, Berzofsky JA, Oh SK.

J Virol. 2007 Aug;81(16):8774-83. Epub 2007 Jun 6.

20.

Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination.

Ota MO, Ndhlovu Z, Oh S, Piyasirisilp S, Berzofsky JA, Moss WJ, Griffin DE.

J Infect Dis. 2007 Jun 15;195(12):1799-807. Epub 2007 May 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk